부품 정보
Md-76r, diatrizoate meglumine and diatrizoate sodium injection, usp; 200ml vial; 12 per case; each milliliter of the contrast agent contains 660 mg of diatrizoate meglumine and 100 mg of diatrizoate sodium, 0.125 mg monobasic sodium phosphate and 0.11 mg edetate calcium disodium; the solution contains approximately 3.65 mg (0.16 meq) sodium in each milliliter and 37% (370 mg/ml) organically bound iodine; store at controlled room temperature 20-25 c (68--77 f); store away from heat and light
TXT
묘사:
Diatrizoate Meglumine And Diatri
MRC:
The peculiar storage feature/s/ required for an item in order to provide the degree of protection necessary to maintain serviceability standards.AJCN
Protective Storage Feature:
Controlled room temperature
MRC:
The ingredients compounded in a pharmaceutical preparation and recognized as having therapeutic value/s/. /usually representative in the item name generic nomenclature./AKJA
Active Medicament Medicinal Strength:
660.0 milligrams diatrizoate meglumine active ingredient and 100.00 milligrams diatrizoate sodium active ingredient and 0.125 milligrams sodium phosphate, monobasic active ingredient and 0.11 milligrams calcium disodium edetate active ingredient and 3.65 milligrams sodium per milliliter and 370.0 milligrams iodine active ingredient
MRC:
The liquid nontoxic component form of a pharmacuetical preparation which normally has no therapeutic action,and presents the active ingredients to the body for absorption.AKJQ
Pharmaceutical Vehicle Type:
Aqueous
MRC:
Those features,not otherwise specified,which may be required for proper functioning of the item.CBBL
Features Provided:
Sterile
MRC:
Indicates the type of container/s/ or supporting device/s/ which is in direct contact with the item.CQCT
Primary Container Type:
Vial
MRC:
A numeric value of the volume,form,or dosage within each primary container.CRLK
Primary Container Content Quantity:
200.0 milliliters
MRC:
The number of primary containers within the item of supply.CSCW
Total Primary Container Quantity:
12
MRC:
An indication of the area,orifice,or tissue of the body to which the medication is administered or applied,based on the drug formulation.CSGS
Administration:
Intravenous
